| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10915974 | Nuclear Medicine and Biology | 2015 | 6 Pages |
Abstract
N-[11C]-methyl-hydroxyfasudil is able to measure increased Rho kinase activity via specific binding in hypertrophied cardiomyocytes and demonstrates the potential for molecular imaging of altered Rho kinase activity in diseases such as cardiac hypertrophy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
![N-[11C]-methyl-hydroxyfasudil is a potential biomarker of cardiac hypertrophy](/preview/png/10915974.png "First Page Preview: N-[11C]-methyl-hydroxyfasudil is a potential biomarker of cardiac hypertrophy")
Authors
Steven Moreau, Jean N. DaSilva, Ana Valdivia, Pasan Fernando,